PRMSX
Price
$54.26
Change
+$1.11 (+2.09%)
Updated
Jul 31 closing price
Net Assets
6.66B
VEMAX
Price
$48.64
Change
+$0.61 (+1.27%)
Updated
Jul 31 closing price
Net Assets
163.32B
Interact to see
Advertisement

PRMSX vs VEMAX

PRMSX vs VEMAX Comparison Chart in %
View a ticker or compare two or three
VS
PRMSX vs. VEMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRMSX is a Buy and VEMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 163B vs. PRMSX (6.66B). VEMAX pays higher dividends than PRMSX: VEMAX (2.32) vs PRMSX (0.47). PRMSX was incepted earlier than VEMAX: PRMSX (31 years) vs VEMAX (20 years). PRMSX (1.23) is less costly to investors than VEMAX (0.13). PRMSX is a more actively managed with annual turnover of: 70.20 vs. VEMAX (6.00). PRMSX has a lower initial minimum investment than VEMAX: PRMSX (2500) vs VEMAX (3000). PRMSX annual gain was more profitable for investors over the last year : 44.07 vs. VEMAX (19.34). VEMAX return over 5 years is better than : 27.49 vs. PRMSX (7.86).
PRMSXVEMAXPRMSX / VEMAX
Total Expense Ratio1.230.13946%
Annual Report Gross Expense Ratio1.230.13946%
Fund Existence31 years20 years-
Gain YTD21.4699.106236%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets6.66B163B4%
Annual Yield % from dividends0.472.3220%
Returns for 1 year44.0719.34228%
Returns for 3 years50.6646.41109%
Returns for 5 years7.8627.4929%
Returns for 10 years73.9889.0883%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFGX30.490.46
+1.53%
BlackRock Capital Appreciation Inv A
OIEQX28.620.24
+0.85%
JPMorgan Equity Income R4
GTLOX23.840.06
+0.25%
Glenmede Disciplined US Eq Ptf
CSDGX17.130.04
+0.23%
Copeland SMID Cap Dividend Growth A
GTMUX24.78-0.03
-0.12%
Goldman Sachs Small/Mid Cap Growth R6